Belatedly, Japan is progressing with more support for vaccine research and development, examination and examination for safety and efficacy. Can it catch up?
The research team is now taking the steps necessary for making the promising drug available on the commercial market at the earliest date possible.
Shionogi’s plans involve regional partners and will help supply vaccine across Asia, providing a balance to China’s expansion of its “vaccine diplomacy”.
Late July reportedly marked the peak of the “second wave” of the novel coronavirus outbreak in Japan. Compared to the earlier state of emergency period,...
As the novel coronavirus pandemic continues, the Japanese drug Avigan has commanded global attention as a front-runner among treatment options for the illness it causes,...
Japan’s Takeda Pharmaceutical Company Ltd. is speeding up the process of collecting the blood of patients who have recovered from COVID-19 in various parts of...
With the ongoing spread of the novel coronavirus, Japan is revving up the development of drugs to treat it. Efforts to repurpose existing drugs have...
